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ABSTRACT
Cardiovascular disease is the leading cause of death in the United States. Millions of patients
suffer each year from endothelial dysfunction and/or debilitating myocardial damage resulting in
decreased quality of life and increased risk of death or disablement. Current pharmacological
approaches are only partly effective at treating cardiovascular disease, and hence, better strate-
gies are needed to provide significant improvements in treatment options. Cardiac stem/progenitor
cells have the potential to regenerate myocardial tissue and repair damaged heart muscle. There are
many different types of cardiac progenitor cells, and each may have certain unique properties and
characteristics that would likely be useful for particular clinical applications. A current challenge
in the field is to identify, isolate, and test specific cardiac stem/progenitor cell populations for their
ability to repair/regenerate myocardial tissue. Our laboratory has discovered a new type of cardiac
progenitor cell that expresses the enzyme, Phenylethanolamine-n-methyltransferase (Pnmt). My
initial studies focused on identification of Pnmt+ cells based on knock-in of a nuclear-localized
Enhanced Green Fluorescent Protein (nEGFP) reporter gene into exon 1 of the Pnmt gene in a
stable recombinant Pnmt-nEGFP mouse embryonic stem cell (mESC) line. These cells were dif-
ferentiated into cardiomyocytes, and I identified nEGFP+ cells using fluorescence, immunofluo-
rescence, and phase-contrast microscopy techniques. Our results showed that only about 0.025%
( 1 per 4000) of the cardiac-differentiating stem cells expressed the nEGFP+ marker. Because of
the relative rarity of these cells, optimization of isolation methods proved initially challenging.
To overcome this technical barrier, I used a surrogate cell culture system to establish the meth-
ods of isolation based on expression of either a fluorescent cell marker (EGFP), or a unique cell
surface receptor represented by an inactivated (truncated) version of the human low-affinity nerve
growth factor receptor (LNGFR). Plasmid DNA containing these reporter genes was transiently
transfected into a permissive cell line (RS1), and reporter gene expression was used to identify
iii
and isolate transfected from non-transfected cells using either Fluorescence-Activated Cell Sorting
(FACS) or Magnetic-Activated Cell Sorting (MACS) methods. The main objective of the study was
to establish the isolation techniques based on the expression of reporter genes (EGFP and LNGFR)
in RS1 cells. Following transfection, EGFP+ cells were successfully isolated via FACS as veri-
fied by flow cytometric and microscopic analyses, which showed that approximately 96% of the
isolated cells were indeed EGFP+. Despite the relative purity of the isolated cell population, how-
ever, their viability in culture following FACS was substantially compromised ( 50% attrition). In
contrast, MACS enabled efficient isolation of LNGFR+ cells, and the vast majority of these ( 90%)
retained viability in culture following MACS. The LNGFR expression was verified using RT-PCR.
Further, MACS methods enabled isolation of marked cells in about 5-7 mins, whereas it took 2-4
hours to using FACS to perform similar isolations from the same amount of starting material ( 106
cells). In addition, MACS is a more economical method in that it does not require the use of an
expensive laser-based instrument to perform the sorting. These results suggest that MACS was
a more efficient, gentle, and feasible technique than FACS for isolation of reporter-tagged mam-
malian cells. Consequently, future studies aimed at isolation of Pnmt+ cardiac progenitor cells will
thus primarily focus on MACS methods.
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I dedicate this work to my brother who has been the support and guidance in my life. He has
made me who I am today. I express my gratitude towards my parents who have been my strength
throughout my life.
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CHAPTER 1: INTRODUCTION
Cardiovascular disease is the leading cause of death in the world. Cardiac tissue is damaged due
to several cardiac diseases such as myocardial infarction, ischemia, heart failure etc. The inability
of the cardiac tissue to regenerate itself has encouraged various researchers to study the processes
leading to cardiac regeneration since organ transplantations have their limitations with availability
of the organ and or rejection.
Stem cell therapy seems to be showing a promising potential in the area of cardiac regeneration.
Stem cells have the ability to get differentiated into cardiomyocytes and hence they can be trans-
planted into the damaged cardiac tissue [1, 3, 9, 2, 4]. Several tissue-specific markers have been
used which help in identification, isolation and characterization of differentiated stem cells such
as neurons, muscle cells, endothelial cells [9, 11, 12, 13, 14, 15, 5]. Some of the key markers
used as cardiac markers are Wnt11, wnt7a, Id2, Nkx2.5, Tbx5 [15, 16, 17, 6, 10, 8, 7]. One
such unique cardiac marker used in differentiating stem cells into cardiomyocytes is the enzyme
Phenylethanolamine n-methyl transferase (Pnmt). Pnmt is one of the enzymes in the biosynthetic
pathway of the adrenergic hormones which helps in conversion of noradrenaline to adrenaline. It
serves as an important cardiac marker as the adrenergic system is found to play a key role in the
development of early embryonic heart [18]. A considerable number of cardiac cells are found to
express this enzyme in the developing and adult heart [23].
Adrenaline is an important hormone and neurotransmitter which plays a pivotal role in the fight
or flight system of the body. It also performs various physiological functions. The adrenergic
hormones were identified in the early embryonic development of chick heart. Huang et al identified
a specific population of cells in the fetal mammalian heart called the Intrinsic Cardiac Adrenergic
Cells (ICA cells) capable of producing adrenergic hormones in vitro [20]. They showed that these
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adrenergic cells were present in the heart even before the sympathetic innnervation of the heart.
One might expect Pnmt to be primarily expressed in adrenal gland primarily during embryonic
development as this is the major site of expression in the adult. However, this was not the case.
Ebert et al showed that Pnmt is expressed in the embryonic rat heart during embryonic day E11.0
and E18 [18]. E11 is the time when the embryonic heart develops in the rat whereas during E18
adrenal gland is in the process of development. This shows that Pnmt is expressed in the heart
before the onset of adrenal gland development. This leads us to a hypothesis that these Pnmt+ cells
are useful in cardiogenesis of the heart during early embryonic development.
Figure 1.1: PNMT mRNA analysis of embryonic tissue and adrenal gland samples [18].
RNase protection assays were performed using total RNA samples from the head, heart, and trunk
regions of E11.0 rat embryos (lanes 1-3, respectively). In addition, total RNA adrenal glands at
E16.0, E17.0, and E18.0 was analysed (lanes 4-6, respectively). The amount of β- actin mRNA
present in each sample is also shown. Figure reprinted from [18].
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The expression of Pnmt is found in the developing heart specifically in the SA node of the embry-
onic heart. This expression was seen during embryonic day 11.5. Figure 1.2 shows Pnmt+ cells
identified using the Pnmt-Cre/R26R mouse model [21]. These cells contribute to the conduction
and pacemaking system of the heart in adults. Further analysis of these cells showed that these
adrenergic-derived cells were found to be concentrated on the left region of the heart specifically
to the left atrium as well as near the base and the midline of the left ventricle [23, 24, 19]. These
cells were positive for sarcomeric -actinin which is a marker for myocytes.
Figure 1.2: Whole-mount XGAL staining of embryonic day E10.5 Pnmt-Cre/R26R embryo.
A: LacZ expression seen in heart, brainstem region, 2nd branchial arch and sporadically along the
dorsal surface of the embryo B: Wild Type mice crossed with R26R mice. Figure reprinted from
[21].
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The above data suggests that the stem cells expressing Pnmt could serve as promising candidates
for regenerative applications of the heart. Mouse embryonic stem cell lines which are adrenergic-
derived, expressing Pnmt as a marker along with additional markers is a novel way for efficient
identification, isolation, and characterization of stem cell generated cardiomyocytes that could be
used in regenerative therapies for damaged cardiac tissue.
In this study, we discuss two different mouse embryonic stem cell (mESC) lines which shall be
used for generating effective cardiac progenitor cells. The two cells lines are Pnmt-nEGFP (nu-
clear enhanced green fluorescent protein)and Pnmt-∆ LNGFR (low affinity nerve growth factor
receptor). My initial objective was to differentiate these mESCs into Pnmt+ cardiac progenitor
cells, isolate and study the characteristics of these cardiomyocytes.
My thesis focuses mainly on establishing the techniques for isolation of these Pnmt+ cardiac pro-
genitor cells. We hypothesize that:
Fluorescence-Activated Cell Sorting (FACS) and Magentic-ACtivated Cell Sorting (MACS) are
effective techniques for isolation of Pnmt+ cardiac progenitor cells.
We have the following aims to test the above stated hypothesis:
1. To isolate enhanced green fluorescent (EGFP+) cells using fluorescent activated cell sorting
(FACS) technique.
In this step we will try to differentiate the Pnmt-nEGFP mESCs into beating cardiomyocytes and
verify Pnmt expression in them and analyze as well as identify the number of nEGFP+ cells. To
establish the FACS technique we will used the adrenergic-derived RS1 cells as the surrogate cells
and transfect with the EGFP plasmid. These EGFP+ cells were then verified using laser-scanning
confocal microscope and will be isolated using FACS technique.
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2. To identify and isolate low-affinity nerve growth factor receptor (LNGFR+) cells using magnetic
activated cells sorting (MACS) techniques.
For this particular aim we utilize the Pnmt∆ LNGFR cell line. The first step is to characterize
these mESCs by genomic screening to verify proper insertion in the mouse genome. The second
step is to establish the MACS technique of isolation where we shall be utilizing the RS1 cells and
transfect it with pMACS LNGFR. These LNGFR+ cells will be isolated using the MACS technique
and LNGFR expression will be verified by RT-PCR analysis.
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CHAPTER 2: ISOLATION OF nEGFP+ CELLS USING FACS
2.1 Introduction
The purpose of this chapter was to isolate nuclear enhanced green fluorescent protein (nEGFP+)
cells using fluorescent activated cell sorting technique. The Pnmt-nEGFP mouse model was made
by inserting the GFP gene in exon 1 of the Pnmt gene locus [25]. Figure 2.1 is the vector diagram
for the Pnmt-nEGFP mouse model. The Pnmt gene encodes for Pnmt enzyme which helps in con-
version of nor- adrenaline to adrenaline in the catecholamine synthetic pathway. The GFP gene
was tagged with an NLS nuclear localization sequence so as to improve the sensitivity and detec-
tion of GFP expression in Pnmt+ cells [25]. The nEGFP gene was targeted under the regulatory
sequences of Pnmt gene so as to co-localize the nEGFP expression with that of the Pnmt expres-
sion [25]. Figure 2.2 shows nEGFP expression in the adult adrenal glands isolated from the mouse
model. The Pnmt-nEGFP mouse model was characterized by verifying the co-localization of the
Pnmt expression in the chromaffin cells of the adult adrenal medullary region in the Pnmt+/nEGFP
mice [25]. The nuclear localized expression of the EGFP protein was confirmed by co-staining
the adrenal sections with Pnmt IF staining as seen in figure 2.3 [25]. EGFP expression was also
seen in the atrio-ventricular sections of the adult heart in this mouse model to confirm that this
mouse model successfully tracks the adrenergic or Pnmt expressing cells [25]. Our main aim was
to isolate Pnmt+ cardiomyocyte progenitor cells from the mouse embryonic stem cells, but due
to some technical difficulties it was hard to differentiate the mESCs into beating cardiomyocytes.
Hence, we focused on getting the methods of isolation worked out so as to facilitate the isolation
of differentiated cardiomyocytes.
6
Figure 2.1: Pnmt GFP alleles. Reprinted from [25]
Figure 2.2: nEGFP expression in mouse adrenal glands
a,b Low magnification views of fluorescent imaging of adrenal gland sections from wild type
control and Pnmt+/nEGFP mice, respectively. Scale bar, 100µm c,d higher magnification of same
image. Scale bar, 50µm Ctx cortex, Med medulla. Reprinted from [25].
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Figure 2.3: Identification of nEGFP and endogenous Pnmt in adrenal chromaffin cells.
a,b Pnmt IF histochemical staining in adult mouse adrenal gland sections as visualized for red
fluorescence c,d EGFP expression in the same adrenal sections but visualized for green
fluorescence (GFP filter) e,f Overlay of Pnmt and nEGFP staining for each section a,c, e Lo-mag
low-magnification: scale bar, 200 µm. b, d, f Hi-Mag high-magnification: scale bar, 30 µm.
Reprinted from [25].
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Figure 2.4: Scheme for isolation of Pnmt+ progenitor cells via FACS
The mESCs will be differentiated into cardiomyocytes via hanging drop method. The nEGFP+
cells in the differentiated cardiac progenitor cells will be identified and quantified. In the next
step, differentiated cardiomyocytes were sorted via FACS and analysed for Pnmt expression at the
end. http://missinglink.ucsf.edu/lm/molecularmethods/flow.htm
2.2 Material and Methods
2.2.1 Materials
Anti-GFP rabbit antibody and Alexafluor 594-conjugated donkey anti-rabbit secondary antibody
were from Invitrogen, Inc. (Carlsbad, CA) Vectashield mounting medium for fluorescence with
DAPI were from Vector Laboratories (Burlingame, CA). All the media cell culture media (Dul-
becco’s Modified Eagle Medium) and supplements were obtained from Invitogen (Carlsbad, CA).
Fetal bovine serum was obtained from Hyclone (Logan, UT). BD Sciences FACS Aria Sorter was
used for sorting of cells by FACS. FBS used for MEF was from Atlanta Biologicals (Flowery
Branch, GA). All the other ingredients and reagents used for the experiments were and Sigma
Aldrich (St. Louis, MO).
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2.2.2 Methods
2.2.2.1 Identification of nEGFP+ cells
The Pnmt-nEGFP mESCs were differentiated using the hanging drop method. During 7+5d the
differentiated cardiomyocytes were stained. The cells were grown on 8 chambered glass dishes.
The cells were rehydrated with PBS for 20 mins followed by incubation with blocking solution
(0.3% Triton X-100, 5% powdered nonfat dry milk, and 0.02% sodium azide in PBS) for 20-30
mins at room temperature. The blocking solution was replaced with blocking solution containing
primary antibody (anti-GFP rabbit antibody) with dilution of 1:100. Cells were incubated with
primary antibody for 2 hrs at room temperature and then at 4 ◦C overnight. After incubation the
cells were washed thrice with PBS and stained with Alexafluor 594 conjugated donkey anti-rabbit
secondary antibody in a dilution of 1:200 for 2 hrs. The cells were given successive washes of PBS
three times, and were mounted using Vectashield mounting medium with DAPI. The images were
captured using 63X objective of Perkin Elmer laser scanning confocal miscroscope. The controls
were stained the same way as described above.
2.2.2.2 RS1 cells transfected with EGFP plasmid
The RS1 cells were transfected with EGFP plasmid using lipofectamine 3000. 30µg of plasmid
DNA was used for a 100mm dish, 43.4µl of lipofectamine and 60µl of p3000 (enhancer reagent).
The media was changed after 4 hours. The cells were harvested about 48 hrs after transfection and
isolated using FACS technique.
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2.2.2.3 FACS of RS1 cells transfected with EGFP plasmid
The RS1 cells were harvested 48hrs after transfection and were centrifuged twice and passed
through a 75µm cell strainer to ensure single cell suspension. The cells were washed with PBS
and re-suspended in flow buffer (1% FBS, 2mM EDTA, PBS)
2.2.2.4 Microscopic analysis
All the images were captured using 63x objective on the Perkin Elmer laser scanning confocal
microscope. The lasers used for capturing images were 488nm for GFP, 561nm for RFP and
405nm for DAPI.
2.3 Results
2.3.1 Identification and quantification of nEGFP+ cells in differentiated beating cardiomyocytes
We used the pluripotent Pnmt-nEGFP mESCs and differentiated them into cardiomyocytes by the
hanging drop method to verify EGFP expression in them. The nEGFP expression was seen at
7+5d in small clusters of cells. The images were captured in red filter set to avoid any disturbance
of autofluorescence. Figure 2.5 shows nEGFP expression in differentiated cardiomyocytes co-
localized with anti-GFP red fluorescence and stained with DAPI to identify the nuclei. If observed
carefully, only 2-3 cells are fluorescently labeled out of the cluster of cells. We counted the number
of nEGFP+ cells out of the total 72,000 cells analyzed and found only 18 of them showed nEGFP
expression or representing 0.025% of the total number of differentiated mESCs. The controls for
these experiments were the undifferentiated pluripotent mESCs. As seen in figure 2.6 there was no
nEGFP expression nor red fluorescence in the pluripotent mESCs.
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Figure 2.5: Identification of nEGFP+ cells in differentiated cardiomyocytes
(a) Endogenous mouse Pnmt gene expression as detected by RT-PCR before and after induction
of cardiac differentiation in mESCs. This procedure takes (7+5d) days. b-g Images of nEGFP+
cells in 7+5d cultures of cardiacdifferentiated mESCs as visualized in green fluorescence for
nEGFP (b), red fluorescence for anti-GFP IF (c), blue fluorescence for DAPI (d),Overlay of bd
images (e), DIC (f), and overlay of bd plus f (g). Arrow indicates the same positively stained
mESC in bg. Scale bar, 10 µm. Reprinted from [25].
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Figure 2.6: Fluorescence expression and staining in control undifferentiated mESCs
(A) nEGFP expression (green). (B) Anti-GFP IF staining (red). (C) DAPI nuclear stain (blue).
(D) Overlay of images obtained in panels A-C. Scale bar, 10 µm. Reprinted from [25].
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2.3.2 Sorting of EGFP+ cells by FACS
RS1 cells are a type of pheochromocytoma derived adrenal medullary cells that are used as surro-
gate cells to establish the methods for isolation of [37]. The RS1 cells were transfected with EGFP
plasmid and sorted by FACS Aria sorter. We analyzed the percent of EGFP+ cells before sort and
found 6.22% of the population were positive for GFP as seen in the dot plot figure 2.7. The cells
were sorted, and both the positive and negative fractions of the cells were collected. We did a flow
analysis on the positive and negative fractions of the cells to verify efficiency of the method. As
seen in the figure 2.7, 92% of the cells were EGFP+ in the positive fraction and absolutely none
were EGFP+ when the negative fraction was analyzed. The controls for the experiment were trans-
fected with (no DNA) lipofectamine and analyzed by flow cytometry. The results showed none of
them were positive for EGFP expression. The same experiment was repeated two more times. Fig-
ure 2.8 shows that during the second trial there were 1.97% EGFP+ cells but none were positive
in the controls. Post sorting approximately 93.7% of the positive fraction showed green fluores-
cence whereas 3.77% were EGFP+ in the negative fraction. During the third trial 2.25% cells were
EGFP+ whereas 0.013% of the controls showed EGFP fluorescence. Post sorting the flow cytome-
try results showed 95.8% cells were green for the positive fraction whereas about 0.60% cells were
showing green fluorescence in the negative fraction.
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Figure 2.7: Dot Plots of RS1 cells (EGFP transfected) Pre and Post sort
Dot plots of the FACS results. A, Presort results. 6.22% of the total RS1 cells were GFP+. The
left gate represents negative population. B,C Post sorting flow cytometric results. 92% were
GFP+ in the positive fraction and none were positive in the negative fraction.
Figure 2.8: FACS(2) Dot Plots of RS1 cells (EGFP transfected) Pre sort
Dot plots of the 2nd trial FACS results. A,B Presort results. 1.97% of the total RS1 cells were
GFP+ in A. The left gate represents negative population. B Presort results for controls show no
EGFP+ cells
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Figure 2.9: Dot Plots of RS1 cells (EGFP transfected) Post sort
A Dot plot of positive fraction shows 93.7% EGFP+ cells. B Representative dot plot of negative
fraction shows 3.77% EGFP+ cells.
Figure 2.10: FACS(2) Dot Plots of RS1 cells (EGFP transfected) Pre sort
Dot plots of the 3rd trial FACS results. A,B Presort results. 2.25% of the total RS1 cells were
GFP+ in A. The left gate represents negative population. B Presort results for controls show
0.013% EGFP+ cells
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Figure 2.11: FACS (3) Dot Plots of RS1 cells (EGFP transfected) Post sort
A Representative dot plot of positive fraction shows 95.8% EGFP+ cells. B Representative dot
plot of negative fraction shows 0.6% EGFP+ cells.
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2.3.3 Microscopic analysis of RS1 cells
The RS1 cells transfected with EGFP plasmid were observed under 63X objective of confocal
microscope pre and post sort. The cells were stained DAPI vectashield. As observed in figures
2.12 and 2.13 there were EGFP+ cells in pre sort and post sort. The controls for the experiment
transfected with just lipofectamine (no DNA) showed no EGFP expression as seen in 2.15.
Figure 2.12: Microscopic Analysis of EGFP+ cells FACS presort
A: DAPI blue nuclear fluorescence, B: GFP fluorescence (green), C: RFP, no red fluorescence , D:
overlay of panels A-C Scale Bar, 21 µm.
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Figure 2.13: Microscopic Analysis of EGFP+ cells FACS postsort
Positive fraction, A: DAPI blue nuclear fluorescence, B: GFP fluorescence (green), C: RFP, no
red fluorescence , D: overlay of panels A-C Scale Bar, 21 µm.
Figure 2.14: Microscopic Analysis of EGFP+ cells FACS postsort
Negative fraction, A: DAPI blue nuclear fluorescence, B: no GFP fluorescence (green), C: RFP,
no red fluorescence , D: overlay of panels A-C Scale Bar, 21 µm
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Figure 2.15: Microscopic Analysis of control(empty transfected) RS1 cells for FACS
A: DAPI blue nuclear fluorescence, B: no GFP fluorescence (green), C: RFP, no red fluorescence ,
D: overlay of panels A-C Scale Bar, 21 µm
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2.4 Discussion
This chapter discusses about Pnmt-nEGFP model. The advantage of this mouse model over the
Pnmt-Cre mouse model is that it tracks the actively Pnmt expressing cells as opposed to the ones
that used to express Pnmt at earlier stages [26]. In this chapter, we induced cardiac differentiation
in the pluripotent Pnmt-nEGFP mESCs by hanging drop method, however, while analysis of the
differentiated cells it was observed that very few cells out of a cluster of cells were nEGFP+. The
undifferentiated cells did not show any kind of nEGFP expression. Pnmt expression was also seen
in these differentiating cells at 7+5d. But it was difficult to observe the green fluorescence due to
autofluorescence and the limited number of cells expressing EGFP. Hence, to have a successful
isolation of the differentiated beating cardiomyocytes we need to scale up the protocol to have
numerous cells facilitating the detection of nEGFP+ cells.
We faced significant technical difficulties trying to differentiate the Pnmt-nEGFP mESCs owing
to several reasons such as use of different lots of fetal bovine serum, inability of the mESCs to
differentiate into cardiomyocytes etc. Therefore, we thought that establishment of the techniques
for isolation of these Pnmt+ cardiac progenitor cells will be a pivotal step. We used RS1 cells as
the surrogate cells for verifying the isolation techniques. RS1 cells are a type of cells derived from
PC12 (pheochromocytoma of rat adrenal medulla) cell line [39, 38, 37, 36]. In a normal healthy
tissue the adrenal medullary cells are of adrenergic type but these pheochromocytoma cells are
thought to have ceased the expression of Pnmt. The RS1 cells were chosen as they are easily
transfectable. We transfected the RS1 cells with EGFP plasmid to establish the FACS method of
isolation. The controls for the experiment were RS1 cells transfected with empty transfection. The
controls and target cells were treated exactly the same, and were sorted by FACS. The positive
and negative fractions of the cell populations were collected and analyzed once the sorting was
completed. It was observed that the positive fraction contained 92% EGFP+ cells whereas the
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negative fraction contained absolutely no EGFP+ cells. The controls for the experiment showed
absolutely no EGFP expression as expected. Both the positive and negative fraction of the cells
were plated post sorting. The cells were microscopically analyzed pre as well as post sorting
and the images were captured under the confocal microscope. The number of EGFP+ cells post
sorting were more as compared to pre sort. FACS was run thrice to verify the sorting technique and
efficiency of the FACS sort. It was observed that during first sort 6.22% of the cells were positive
for EGFP whereas 2.5 and only 2.0% for the next two sorts. The variation in the percentage of
EGFP+ cells was due to the varying transfection efficiencies of the transfection regents used.
2.5 Limitations
As discussed in the previous section a major technical challenge in identifying the EGFP+ cells
was autofluorescence. Since the EGFP+ cells were found in low abundance it made it further
difficult to observe and identify them. But these challenges can be overcome by taking certain
steps. The disturbance due to autofluorescence was minimized by using a red fluorescent anti-GFP
antibody which facilitated the identification cells showing EGFP expression. The low abundance
of cells expressing EGFP can be overcome by increasing the number of differentiating cells. We
have been exploring newer methods of differentiation which would help improve the efficiency of
cardiac differentiating cells. Another limitation was the expression of EGFP in Pnmt+ cells. It
was seen in adrenal glands isolated from the Pnmt-nEGFP mouse model that only a few number
of Pnmt+ cells expressed EGFP protein. There might be several reasons of this limited expression
of EGFP in Pnmt expressing cells.
Another major technical difficulty observed before and after FACS technique was the viability and
survival rate of the cells. Since the cells were exposed to such high pressures and high intensity
lasers the health of the cells was compromised. It took almost 2-2.5 hours for each sort to get
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completed which made the cells devoid of media and fetal bovine serum hence decreasing their
viability. It was also observed that only about 50% of the total number of fluorescent cells in reality
get sorted out. In addition to that, a very few number of the sorted cells remained actually viable
post-sort.
2.6 Conclusions
This chapter primarily focuses on isolation of nEGFP+ cells based on the FACS technique. Pnmt-
nEGFP mESCs were differentiated into cardiomyocytes, and nEGFP+ cells were identified in the
differentiated cardiomyocytes. Figure 2.4 gives a general scheme for differentiation and isolation
of Pnmt-nEGFP+ cells via FACS technique. The results show that the mESCs were successfully
differentiated into cardiomyocytes and expressed nEGFP and Pnmt post differentiation. To es-
tablish the FACS technique we used the RS1 cells derived from the pheochromocytoma cells of
adrenal medulla and transfected them with the EGFP plasmid and isolated the cells using FACS
technique. The results confirm that EGFP+ cells were successfully isolated using the FACS tech-
nique and therefore, this technique could be used for isolation of Pnmt-nEGFP expressing differ-
entiated cardiomyocytes. In the future, this isolation technique will enable us to isolate and study
the characteristics of the cardiac progenitor cells.
23
CHAPTER 3: ISOLATION AND IDENTIFICATION OF LNGFR+ CELLS
3.1 Introduction
As we discussed in the previous chapter, Pnmt-nEGFP mESCs have several limitations when it
comes to differentiation and isolation of Pnmt+ cardiomyocyte progenitor cells. Not only is it
difficult to detect the nEGFP expression in differentiated cardiomyocytes, but the expression is not
robust and was observed in low abundance.
Hence, another mouse embryonic stem cell line was generated containing a unique cell surface
marker, ∆LNGFR. ∆LNGFR is a cell surface epitope, a type of neurotrophin receptor which is
primarily expressed in the central and peripheral nervous system. ∆LNGFR is a C-terminal non-
truncated version of the protein as well as human in origin which makes it an ideal and unique
reporter gene as it will be expressed in cells only transfected with the above mentioned gene. It
was seen that ∆LNGFR is already used a marker to enrich a specific population of cells by a
an isolation technique called (Magnetic Activated Cell Sorting) MACS. It may serve as a better
method than FACS as it is said to be less harsh than FACS and more efficient.
This Pnmt-∆LNGFR cell line was created by Jixiang Xia (in his thesis) using a strategy similar
to that need to develop the Pnmt-nEGFP cell line. The cDNA of ∆LNGFR and neomycin is
inserted into the Pnmt 5’ and 3’ flanks under the Pnmt 5’ regulatory sequences as seen in figure
3.1. Diphtheria toxin A fragment (DTA) was used a negative marker. Since the ∆LNGFR cDNA
is inserted into the downstream regulatory sequences of Pnmt gene, it should be expressed only
in the cells expressing Pnmt gene. This entire construct of ∆LNGFR cDNA along with Pnmt 5’
and 3’ flanks was inserted into the YFP mESCs by electroporation. The YFP mESCs is a cell line
containing the yellow fluorescent protein in it.
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Figure 3.1: Schematic map of Pnmt-∆LNGFR-Neo targeting construct (Created by Jixiang Xia
Figure 3.2: Scheme for isolation of LNGFR+ cells
Figure adapted from Milteyni Biotec
Figure 3.2 gives a schematic representation of the MACS technique. Once the cells express the
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∆LNGFR epitope on the surface they will be labeled with MACS anti-LNGFR microbeads (pro-
vided by Milteyni Biotech). The microbeads are 50µm in size have a magnetic component at-
tached to the antibody. The cells expressing the surface epitope will have the magnetic microbeads
attached to them. These cells will be passed on to a magnetic column which is attached to a
magnetic separator. Since the microbeads have a magnetic component attached to it, the cells ex-
pressing the ∆LNGFR marker will get retained in the column whereas the others will elute out of
the column. Both the positive and negative fractions of the cells can thus be analyzed for further
experiments.
The purpose of generating this Pnmt-∆LNGFR mouse embryonic stem cell line was to have an
efficient technique for isolation of the Pnmt+ cardiac progenitor cells. The same principle of
differentiation shall be applied to these mESCs for induction of cardiac differentiation.
In this chapter we will discuss about characterization of Pnmt-∆LNGFR cell clones and establish-
ment of the MACS technique. The first step is to characterize the ∆LNGFR cell line by genomic
screening to verify if the construct was properly inserted into the mouse genome. Post characteriza-
tion of the cell clones and establishment of the MACS technique this cell line could be effectively
used to induce cardiac differentiation in the Pnmt-∆LNGFR mESCs and isolate them using the
MACS technique so as to further study the characteristics of the adrenergic progenitor cells for
future cardiac regenerative applications.
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3.2 Materials and Methods
3.2.1 Materials
Anti-LNGFR FITC antibody, anti-LNGFR APC antibody, pMACS LNGFR plasmid, anti-LNGFR
magnetic microbeads, MS columns and the entire MACS apparatus was obtained from Milteyni
Biotec Inc. (San Diego, CA). The primers for PCR and RT-PCR were obtained from Promega
(Madison, WI). DMEM (Dulbecco’s Modified Eagle Medium) and other supplements for cell cul-
ture were from Invitrogen, Inc.(Carlsbad, CA). All the other supplements were from Sigma Aldrich
(St Louis, MO). Fetal bovine serum was from Atlanta Biologicals (Flowery Branch, GA. Lipofec-
tamine 2000 and 3000 were obtained from Invitrogen, Inc. (Carlsbad, CA), BD Sciences FACS
Aria sorter and FACS canto was used for sorting of cells and for flow cytometry respectively.
3.2.2 Methods
3.2.2.1 Characterization of ∆LNGFR: Genomic Screening by PCR
We designed primers L1, L2, L3, L4, L5, Neo, L6, LNGFR primers for verifying specific junction
points for the fragment inserted in mouse genome and the for evaluating the presence LNFGR
gene. Table 3.1 lists the primers used for genomic screening. We screened 18 Pnmt-∆LNGFR cell
clones of which three clones namely LN9, LN10, and LN43 showed positive results.
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Table 3.1: Primers Used for Genomic Screening
Primer Name Primer Sequence
L1 AGAAGTGTCCTCTCCCCTGC
L2 GGGGGACCCAGTGGTAGA
L3 CACCTGCCCCCATCGC
L4 GTGGTATGGCTGATTATAGCAGG
L5 CACTCCCTGTAGCGTGCTT
L6 GTGTCAGGTGAGCACTTGGG
Neo CGATTGTCTGTTGTGCCCAG
LNGFR (F) GGTGATAGCTTCGATCCAGACA
LNGFR (R) CCGCCTCAGAAGCCATAGAG
3.2.2.2 Restriction Digestion of pMACS LNGFR plasmid
We performed digestion of pMACS LNGFR plasmid to verify the plasmid. The digestion was
done by using 2.5µl buffer, 1µg DNA, 1-2µl restriction enzyme, about 0.5µl BSA and water in a
20µl reaction. The reaction was incubated for 1 hr at 37 ◦C. Once the reaction was complete about
5µl dye was added and was observed on agarose gel.
3.2.2.3 Transfection of RS1 cells with pMACS LNGFR plasmid
The RS1 cells were transfected with pMACS LNGFR plasmid and control for the experiment were
empty transfected RS1 cells. The cells were transfected with 30µg of plasmid, 60µl of P3000
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(enhancer) and 43.4µl of lipofectamine 3000. The protocol was as specified in the manufacturer’s
kit. The transfection was verified by treating the transfected cells (both the control and the target)
with anti-LNGFR antibody. 10µl of antibody was used for 107 cells in 100µl of MACS buffer
(PBS containing 0.5% BSA)
3.2.2.4 Isolation of ∆LNGFR+ cells by MACS technique
The cells were trypsinized and centrifuged twice and passed through a 70µm cell strainer to ensure
ingle cell suspension. The cells were then re suspended in 80µl of buffer. 20µl of anti-LNGFR
microbead suspension was added to the cells and they were kept in dark for 15-20 mins at 4 ◦C.
The cells were then washed with PBS. A minimum of 108 of total cells were resuspended in
degassed MACS buffer. The MACS column was rinsed with 1ml of buffer, which was discarded.
The remaining cell suspension was then fed into the column. The unlabeled cells were passed and
collected in a tube. MS column was washed with 3x500 µl degassed buffer, adding buffer every
time as the column got empty. The MS column was then removed from the separator and 1 ml of
buffer pipetted into the column and plunged so as to collect the retained the cells. The flow-through
was passed once again in a new column using the same protocol, and the flow-through and retained
cells were collected. The protocol was as specified in the manufacturer’s kit (Milteyni Biotec).
3.2.2.5 Isolation of ∆LNGFR+ cells by FACS
We also isolated ∆LNGFR+LNGFR+ cells using FACS. In this experiment the control for the
experiment were empty transfected RS1 cells. The control and target samples were harvested after
48 hrs of transfection and treated with anti-LNGFR antibody FITC (provided by Milteyni Biotec,
Inc). The cells were suspended in 100µl MACS buffer with 10µl antibody and incubated in the
dark for 15 mins at 4 ◦C. They were washed twice with PBS, passed through 75µm cell strainer and
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resuspended in flow buffer. Both the positive and negative fractions were collected and analyzed
by flow cytometry to verify the percentage of LNGFR+ cells (green cells). The controls were
also analyzed for green fluorescence by flow cytometry. In addition, all the populations of cells
including the controls, positive and negative fractions post FACS and pre sorted cells were analyzed
microscopically before and post sorting to confirm green fluorescence.
3.2.2.6 RT-PCR
RNA was extracted from both the positive and negative fractions of the controls as well as the target
cells (cells transfected with pMACS LNGFR plasmid) by TRIzol reagent and cDNA was gener-
ated using MuLV Reverse Transcriptase. LNGFR primers used for RT-PCR were obtained from
operon and a 1:20 dilution was used for analysis. They were as follows: forward 5’ CCGTTGGAT-
TACACGGTCCA 3’ and reverse 5’ TGTCTGGATCGAAGCTATCACC 3’. The product size was
265 bp which was observed on agarose gel. The RT-PCR analysis was done on all the four popu-
lations collected from MACS namely Lipo +ve (control retained), Lipo -ve (ontrol flow through),
MACS positive or LN+ (MACS retained), MACS negative or LN- (MACS flow through). GAPDH
expression was used as a control for the experiment. The primers used for verifying GAPDH ex-
pression were as follows: forward 5’ AGAGATGATGACCCTTTTGGC 3’ and reverse 5’ CCAT-
CACCATCTTCCAGGAGCG 3’.
3.2.2.7 Confocal Microscopy
All the images were captured on the 63x objective of Perkin Elmer laser scanning confocal mi-
croscope. The images were captured using the following lasers: 488nm for GFP, 563nm for RFP,
405nm DAPI and DIC.
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3.3 Results
3.3.1 Genomic Screening of Pnmt-∆LNGFR ES cells
Figure 3.3 shows the scheme used for genomic screening and characterization of the Pnmt-∆LNGFR
ES cells. Out of 18 clones that were screened, three clones showed the presence of LNGFR cDNA,
the NeoR, and the Pnmt 5’ and 3’ flanks. The clone numbers were LN9, LN10 and LN43. Figure
3.4 provides the size of bands generated for each of these constructs.
Figure 3.3: Scheme for Genomic Screening of Pnmt-∆LNGFR ES cells
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Figure 3.4: Results of Genomic Screening
Left panel: Gel Electrophoresis, Right panel: Schematic showing band sizes
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Figure 3.5: Restriction analysis of pMACS LNGFR plasmid
3.3.2 Restriction Digestion of pMACS LNGFR
Figure 3.5 shows the bands observed under agarose gel electrophoresis after restric digestion of
the plasmid. Table 3.2 specifies the enzymes used for restriction digestion of the plasmid.
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Table 3.2: Enzymes Used for Digestion of pMACS LNGFR
Lanes Enzyme Used Band size (bp)
1 Ladder 1kb
2 BamH1 1156, 4289
3 ECoR1 5445
4 Xho1 1178, 4269
5 Hind III 5445
6 No enzyme
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3.3.3 FACS of RS1 cells transfected with pMACS LNGFR and stained with FITC anti-LNGFR
antibody FITC
The RS1 cells transfected with pMACS LNGFR plasmid were treated with anti-LNGFR anti-
body and the cells were sorted via FACS. This experiment was performed twice with the con-
trols being the empty transfected RS1 cells. In the first sort 7.15% of the cells were FITC and
hence ∆LNGFR+ whereas the controls showed absolutely no fluorescence. Once the cells were
sorted the positive and negative fraction were analyzed by flow cytometry. 98.4% of the cells
were ∆LNGFR+ in the positive fraction whereas 0% were ∆LNGFR+ in the negative fraction
post sorting. During the second sort 2.34% were ∆LNGFR+ whereas 0.030% were positive in the
control experiment. Post sorting the positive fraction showed 96% LNGFR+ cells whereas 0.012%
cells were LNGFR+ for the negative fraction. The difference in the percentage of ∆LNGFR+
cells in FAC1 and FAC2 results pre sorting was because of the different types of lipofectamines
used for transfection of RS1 cells. During first transfection lipofectamine 2000 was used whereas
lipofectamine 3000 was used for the second transfection experiment.
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Figure 3.6: Dot plots of RS1 cells transfected with LNGFR plasmid and stained with anit-LNGFR
FITC antibody
(A) Presort of LNGFR transfected RS1 cells B Presort of empty transfected RS1 cells. 7.15% of
the total RS1 cells were LNGFR+ in A. The left gate represents negative population. (B) Presort
results for controls show 0.0% LNGFR+ cells
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Figure 3.7: FACS Post Sort cytometry results
A Post sort positive fraction shows 98.4% ∆LNGFR+ cells. B Post sort negative fraction shows
0.0% ∆LNGFR+ cells.
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Figure 3.8: FACS of RS1 cells transfected with LNGFR plasmid and stained with anit-LNGFR
FITC antibody
Post sort dot plots of FACS A,B Presort results. 2.34% of the total RS1 cells were ∆LNGFR+ in
A. The left gate represents negative population. B Presort results for controls show 0.03%
∆LNGFR+ cells
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Figure 3.9: Post Sort cytometry results
(A) Post sort positive fraction shows 96.1% ∆LNGFR+ cells. (B) Post sort negative fraction
shows 0.012% ∆LNGFR+ cells.
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3.3.4 Isolation of LNGFR+ cells using MACS technology
Figure 3.10 gives a detailed method for isolation ∆LNGFR+ cells using MACS technique. The
same experiment was performed three times to verify the validity of the experiment. The controls
for the experiment were empty transfected RS1 cells. The transfection with LNGFR plasmid was
confirmed by staining the cells with anit-LNGFR antibody.
Figure 3.10: Magnetic separation of RS1 cells transfected with pMACS LNGFR plasmid
The cells were transfected with LNGFR plasmid and treated with anti-LNGFR microbeads and
fed into the MACS column. The flow though and retained cells were collected and counted. The
controls (empty transfection) were treated similary. Figure adapted from Milteyni Biotec
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3.3.5 Analysis of MACS technique
Tables 3.3, 3.4 & 3.5 show the initial count of cells and number of cells retained and in flow through
for both the control and the target cells (pmacs LNGFR transfected). This data is plotted in the
form of graphs in figures 3.11 and 3.12.
Table 3.3: Analysis of MACS1 Technique: A
Target (∆LNGFR RS1 cells) transfected with pMACS LNGFR plasmid treated with anti-LNGFR
microbeads and isolated using MACS technique. Analysis was done by counting the initial
number of cells, cells retained in the column and the flow through fractions. The controls (empty
transfection) were treated similary.
Control (Lipofectamine RS1 cells) Target (∆LNGFR RS1 cells)
Initial number of cells 1.4× 107 cells 8.05× 106 cells
Cells Retained 2× 104 cells (0.142%) 1.95× 106 cells (24.22%)
Flow Through 8.32× 106 cells (59.4%) 3.82× 106 cells (47.45%)
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Table 3.4: Analysis of MACS2 Technique: B
Target (∆LNGFR RS1 cells) transfected with pMACS LNGFR plasmid treated with anti-LNGFR
microbeads and isolated using MACS technique. Analysis was done by counting the initial
number of cells, cells retained in the column and the flow through fractions. The controls (empty
transfection) were treated similar.
Control (Lipofectamine RS1 cells) Target (∆LNGFR RS1 cells)
Initial count of cells 4.02× 106 cells 5.6× 106 cells
Cells Retained 0 cells (0.0%) 2.1× 105 cells (3.75%)
Flow Through 1.81× 106 cells (45.0%) 2.34× 106 cells (41.7%)
Table 3.5: Analysis of MACS3 Technique: C
Target (∆LNGFR RS1 cells) transfected with pMACS LNGFR plasmid treated with anti-LNGFR
microbeads and isolated using MACS technique. Analysis was done by counting the initial
number of cells, cells retained in the column and the flow through fractions. The controls (empty
transfection) were treated similar.
Control (Lipofectamine RS1 cells) Target (∆LNGFR RS1 cells)
Initial count of cells 7.44× 106 cells 6.44× 106 cells
Cells Retained 0 cells (0.0%) 8.722× 105 cells (13.477%)
Flow Through 6.34× 106 cells (85.2%) 4.95× 106 cells (76.7%)
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Figure 3.11: Percent of Total RS1 cells in flow through and retained.
The results show percent of total cells (empty transfection) in the flow-through and retained. For
MACS1, 2 and 3: 60, 45 and 85% of the cells were flow through whereas almost zero or
negligible were retained.
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Figure 3.12: Percent of Total RS1 cells in flow through and retained.
The results show percent of total cells (pMACS LNGFR transfected) in the flow-through and
retained. For MACS1, 2 and 3: 47.45%, 41.7% and 76.7% of cells were flow through whereas
24.22%, 3.75% and 13.477% of the cells were retained.
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3.3.6 RT-PCR Analysis
Relative fold-change in the expression of ∆LNGFR gene was evaluated in MACS-retained, MACS
flow- through and control-retained, and control flow through as the reference for calculation ac-
cording to the ∆ ∆Ct method. ∆LNGFR expression was observed in both MACS retained and
flow through fractions of the cells. This shows that some ∆LNGFR+ cells are present in the eluted
fraction of the cells as well. However, the ∆LNGFR expression was almost double in the case of
MACS retained population. The RT-PCR was run and respective bands of LNGFR and GAPDH
(control) were observed on the agarose gel electrophoresis. Figures 3.14 and 3.16 are the gel
images showing GAPDH and LNGFR bands. Figure 3.15 shows there were no bands in control
retained and flow-through fractions.
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Figure 3.13: RT-PCR Analysis: ∆LNGFR expression in RS1 Cells Isolated by MACS Technology
MACS 1, MACS2, MACS3 are the three trials of MACS. Control flow-through is eluted fraction
of the control cells. MACS retained: Positive fraction of RS1 cells tranfected with pMACS
LNGFR plasmid and retained in MS column. MACS flow through: Negative fraction of RS1 cells
tranfected with LNGFR plasmid. Relative fold change expression of ∆LNGFR was ≥ double in
case of MACS retained to that of MACS flow-through.
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Figure 3.14: RT-PCR Analysis: LNGFR positive bands
RT PCR run on all four population of cells post MACS isolation. MACS retained, MAcs flow
through, Control retained, control flow through. Bands (264bp) were observed for MACS
retained and MACs flow through. No bands were seen for negative control (no DNA).
Figure 3.15: RT-PCR Analysis:Negative controls
No LNGFR bands seen in Lipo negative and Lipo positive populations. Lanes 2-5: Lipo +ve,
Lanes 6-9: Lipo -ve, Lanes 10-13: Null controls, no cDNA
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Figure 3.16: RT-PCR Analysis: GAPDH gel
GAPDH used as a control for RT-PCR. Gel shows bands for all the samples including LN+, LN-,
Lipo +ve, Lipo -ve. No bands are seen for the null controls, Lanes: 10-11. Expected size is
147bp.
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3.3.7 Fluorescence Microscopy Analysis
Figure 3.17, figure 3.18, figure 3.19 and figure 3.20 correspond to microscopic analysis of cells pre
and post isolation of the ∆LNGFR+ cells via FACS technique.
Figure 3.17: Fluorescence Microscopy Analysis of ∆LNGFR+ cells presort
Cells stained with anti-LNGFR FITC antibody. A: DAPI blue nuclear fluorescence, B: FITC
fluorescence (green) around the nucleus, C: RFP, no red fluorescence , D: overlay of panels A-C.
Scale bar, 21µm.
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Figure 3.18: Fluorescence Microscopy Analysis of ∆LNGFR+ cells
Cells stained with anti-LNGFR FITC antibody, Post sort positive fraction. A: DAPI blue nuclear
fluorescence, B: FITC fluorescence (green) around the nucleus, C: RFP, no red fluorescence , D:
overlay of panels A-C Scale bar, 21µm.
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Figure 3.19: Fluorescence Microscopy Analysis of ∆LNGFR+ cells
Cells stained with anti-LNGFR FITC antibody, Post sort negative fraction. A: DAPI blue nuclear
fluorescence, B: no FITC fluorescence (green) around the nucleus, C: RFP, no red fluorescence ,
D: overlay of panels A-C Scale bar, 21µm.
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Figure 3.20: Microscopic Analysis of control cells
Cells stained with anti-LNGFR FITC antibody, A: DAPI blue nuclear fluorescence, B: no FITC
fluorescence (green) around the nucleus, C: RFP, no red fluorescence , D: overlay of panels A-C
Scale bar 21µm.
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3.4 Discussion
∆LNGFR is a very useful cell surface marker used for isolation of cell populations. A study
conducted by Jianping Zhang showed effective isolation of LNGFR+ neural crest-derived stem
cells from rat embryonic mandibular processes by using the MACS technique [27]. The results
clearly showed that LNGFR antibodies are very specific and enabled enriched and pure popula-
tion of these stem cells. Not only did it help in isolation of ∆LNGFR+ cells but in this particular
study they differentiated these LNGFR+ cells into muscle, bone and melanin secreting cells by
supplementing them with some special growth factors [27]. This shows that MACS is effective in
enrichment of LNGFR+ cells and does not compromise on viability of the cells. It is less tough
on the cells, and it is less time-consuming. Another advantage is the isolation of about 107 cells in
a single isolation is possible in about 5-7 mins whereas it takes 2-4 hours for isolation via FACS.
Another study showed staining of bone marrow mesenchymal cells using monoclonal antibodies
against α-LNGFR [28]. These stem cells post isolation were assessed for their proliferative ca-
pacity and various other properties after differentiation [28]. This shows that in future once the
Pnmt+ cardiac progenitor cells are isolated on basis on LNGFR expression, they could be readily
characterized for numerous characteristics such as proliferative potential, differentiation potential,
transplantation etc.
There are several other studies where MACS technology is effectively used for isolation of rat hair
follicle stem cells, purification of differentiated ES cells expressing CD4 as surface marker. All
these studies suggest effective purification of stem cells or other type of specialized cells which
were cultured post MACS isolation and proved to be efficient in enrichment of the cells [29, 30,
31]. The same principle was used in this study to isolate LNGFR+ cells. Since the viability and
proliferative potential of the enriched cells was not compromised this technique of isolation has
great potential to generate enriched and pure populations of Pnmt+ cardiac progenitor cells based
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on the expression of ∆LNGFR as as surface receptor.
3.5 Limitations
Though we were able to identify the specific junction points of the Pnmt-∆ LNGFR mESCs, we
could not verify if the construct was homologously recombined with the mouse genome. We
tried long-range PCR technique but since the products were about 3kb and 8kb, it was difficult
to amplify such a huge construct. But the homologous recombination could also be verified by
southern blot technique.
We were able to successfully isolate the ∆LNGFR+ cells by using the MACS technique. However,
there were some minor technical difficulties we faced during the actual process of the MACS
technique. When the RS1 cells expressed LNGFR on the surface of the cells, an aliquot of the
cells was stained with anti-LNGFR anti-body to confirm transfection. During this step the cells
were suspended in about 100µl of MACS buffer and 10µl of antibody was added and they were
kept in the dark at 4C for 10-15 mins. It is very important to have a high population of cells in a
specified volume of buffer. If the anti-LNGFR antibody is less or the population of the cells is less,
it becomes difficult to stain the LNGFR expressing cells.
Another drawback of the MACS technique is verification. Once the cells are labeled with anti-
LNGFR magnetic microbeads, there is no way to confirm that the microbeads have attached to the
surface antigen of the cells. Miltenyni Biotec has provided us with a MACS control FITC antibody
but we are facing some difficulties in getting the microbeads stained with the antibody. The only
way to test the efficiency of MACS and labeling of the cells with the antibody is after the isolation
of ∆LNGFR+ cells by RT-PCR analysis. The anti-LNGFR antibody could be eventually used for
verifying ∆LNGFR expression in the differentiated cardiomyocytes as well as pluripotent Pnmt-
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∆LNGFR ES cells. Since the ES cells have a YFP gene, it is difficult to use the FITC conjugated
antibody to verify ∆LNGFR expression as the excitation emission peak of YFP is in the range of
FITC absorption peak. But the Milteyni Biotec provide an APC conjugated anti-LNGFR antibody
which could be used to stain the ES cells as well as the differentiating cardiomyocytes.
3.6 Conclusions
We successfully identified ∆LNGFR cDNA in 3 out of 18 clonees flanked by Pnmt 5’ and 3’ flanks.
We could isolate the ∆LNGFR+ cells via MACS technique and verify the expression of LNGFR
in the isolated samples as well as in the controls. This shows that the MACS technique is efficient
in isolation of ∆LNGFR cells. We also noticed that the ∆LNGFR cells could be isolated by FACS
technique by staining them with the anit-LNGFR FITC antibody. The isolation of ∆LNGFR cells
by FACS technique could serve as an alternative technique.
Hence, MACS can be effectively used for isolation of the Pnmt-∆LNGFR cardiac progenitor cells
and it could serve to be a better and efficient technique for isolation of Pnmt+ cardiac progenitor
cells.
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CHAPTER 4: SUMMARY AND CONCLUSIONS
The purpose of this thesis was to establish the methods of isolation for Pnmt+ cardiac progenitor
cells. This was shown using both FACS and MACS techniques.
In chapter 2, we described about the Pnmt-nEGFP mice cell lines and the initial characterization of
the Pnmt-nEGFP differentiated cardiomyocytes. We could clearly identify the number of nEGFP+
cells in a population of differentiated cardiomyocytes. There were about 0.025% nEGFP+ cells
found on 7+5d. The Pnmt expression in these cells was verified by RT-PCR analysis. The controls
for this experiment were the undifferentiated pluripotent mouse embryonic stem cells which clearly
did not show any kind of green fluorescence or red fluorescence of the anti-GFP antibody. We also
discussed about the technical difficulties faced during differentiation of these mESCs. We have
been working hard to increase the percentage of differentiated cardiomyocytes so as to facilitate
the nEGFP fluorescence. Also, while identifying and counting the number of nEGFP+ cells, it
was difficult to observed and identify them owing to the disturbance of autofluorescence and low
abundance of nEGFP+ cells. The nEGFP expression was not robust amongst the differentiated
cells which could be attributed to the variability of green fluorescence expressed by the EGFP
reporter gene. However, we were able to successfully isolate the surrogate RS1 cells transfected
with EGFP plasmid via the FACS technique. The cells were sorted efficiently and verified by laser
scanning confocal microscopy and flow cytometry. The technique is efficient but compromises
health of the cells. It was seen that only 50% of the effective green fluorescent cells were sorted
by FACS technique. Once the cells were sorted, the health of the cells is highly compromised due
to which most of the cells perish due to the harsh conditions of FACS technique since the cells are
exposed to so much pressure and are without the media for about 2-3 hours. This shows that to
efficiently sort the Pnmt+ cardiac progenitor cells via FACS technique we need to have an abundant
population of cells and we should also work on the technical specifications of FACS technique so
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that technique is less rough on the cells.
In chapter 3, we described other cells lines where Pnmt-∆LNGFR was developed. Instead of the
nEGFP reporter gene, we have the ∆LNGFR gene inserted in the exon 1 of Pnmt gene. Our first
step in this chapter was to characterize the cell clones to evaluate the construct is inserted in the
respective exon in the mouse genome flanked by the Pnmt flanks. We were able to successfully
identify the ∆LNGFR cDNA flanked by the Pnmt flanks by using PCR genomic screening. We
were unable to verify if the 3 clones expressing this contruct were homologously recombined with
the mouse genome due technical difficulties faced owing to the large amplicon sizes required to
be generated. We could successfully isolate the ∆LNGFR+ cells via MACS technique. The only
problems faced for this technique was the verification of labeling of the ∆LNGFR cells with the
magnetic microbeads. But we were able to successfully verify LNGFR expression in both the
positive and negative fraction of the cells. It was found that the ∆LNGFR expression was almost
double for positive fraction as compared to the negative fraction cells eluted out. This shows that
the MACS technique could efficiently isolate ∆LNGFR+ cells. Hence this technique could be
effectively used in the future for isolation of Pnmt+ cardiac progenitor cells. LNGFR could also
be used as an efficient marker for isolation of other Pnmt+ cells found in other regions of the body
such as brain, kidney, liver, eyes etc.
The main purpose of the study was to establish the isolation techniques that would enable isolation
of Pnmt+ cardiac progenitor cells in future studies. From the above discussion we could conclude
that the MACS technique is technique of choice for isolation of Pnmt+ cardiac progenitor cells.
There are several reasons for this conclusion which could be summarized as follows: we found
that FACS technique was much harsher on the health of the cells which hampered the viability of
cells resulting in very few cells being actually isolated via the technique. On the other hand, the
MACS technique is much easier to handle and use. It facilitates effective isolation of ∆LNGFR+
cells without compromising the viability of the cells. Other important points to consider are time
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and money. MACS technique is a much quicker and less time consuming technique as compared
to FACS. The apparatus used for MACS is easy to use and relatively inexpensive. In case of FACS,
if about 2% of the cell population was fluorescent during presort, it was observed that about 50-
70% of this 2% population was actually sorted out. Of these 50% about 10-20% of the cells were
dead because of the through-put pressure that the cells are exposed to during FACS technique.
Though during successive trials of MACS technique we observed that about 50% of the cells were
getting lost. This could be due to decrease in the viability of the cells or a large number of cells
must be retained in the column. But this was overcome during the third trial where we washed
the MS column three times with the MACS buffer so as to get as many cells as possible from the
MS column. We also passed the enriched fraction of the ∆LNGFR cells once more through a
new MS column so as to enrich the ∆LNGFR+ cells. Following precautions and measure enabled
us to retrieve as many cells as possible in addition to an enriched ∆LNGFR population. Exactly
same scenario was seen in a study conducted by Li et al where they try to compare these two
isolation techniques to effectively isolate third generation bone marrow mesenchymal stem cells.
The viability of these stem cells was much lower than the stem cells isolated by MACS technique
[32]. A study showed the comparison of two methods for isolation of CD4+ CD25+ regulatory
T (Treg) cells. The cells were isolated by both the techniques and analyzed by trypan blue and
propidium iodide for evaluating the cell viability. For this particular study they observed MACS
took more time and was challenging to sort the cells as compared to FACS. However, they suggest
using both the methods simultaneously for higher purity of cells.
However, there are certain criteria which should also be taken into consideration while selecting
the best possible method of isolation. FACS is an ideal method of enrichment when you desire
highest purity of cells and recovery. Also, FACS could be used for isolation of proteins based
on their intracellular characteristics whereas MACS is solely based on expression of cell surface
proteins [32]. Another important point to consider is the magnet used for isolation of cells in
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MACS is very powerful which isolates anything and everything that is attached to the microbeads
[32]. Another drawback of using MACS technique is the lack of purity [32]. We noticed LNGFR
expression in the flow through fractions as well which concludes presence of LNGFR+ cells in
this population of cells. Another point to be considered is with MACS you could isolate only one
type of cell population as opposed to FACS which enables collection of atleast 2-4 different cell
populations [33]. The shape, granularity and viability of cells is also an important criteria. With
FACS you easily set gates so as to avoid collecting the dead cell population whereas MACS is
unable to distinguish the dead cells from the live ones. If the cells are sticky and and irregular
shape they tend to stick to the MS column resulting in loss of cells [34]. Considering all the
points the most favorable technique to be employed for isolation of Pnmt+ cardiac progenitor cells
is MACS followed by FACS. This would help in achieving a highly pure population of enriched
cells. Otherwise, one could also use MACS to facilitate enhanced viability of cells.
In the introduction we discussed that Pnmt+ cells were found during early embryonic develop-
ment of heart. It was also observed that these Pnmt+ cells contributed to a major chunk of the
left ventricular chamber of heart which is most susceptible to cardiac damage during several car-
diovascular diseases. There could be a question as to why these Pnmt+ cells could be useful for
cardiac regenerative applications. We are yet to confirm if these Pnmt+ cells could serve as an
important tool for regenerative applications or not. They might also serve as a tool for destruction
of cardiac myocardium owing to their association with the sympathetic system of the body. Never-
theless, isolation of these Pnmt+ cells will definitely enable us to study the characteristics of these
cardiac progenitor cells enable us to conclude if these Pnmt+ cells could be useful for regenerative
applications.
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